Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gossamer Bio (GOSS) Change in Accured Expenses (2022 - 2025)

Gossamer Bio's Change in Accured Expenses history spans 4 years, with the latest figure at $25000.0 for Q4 2025.

  • For Q4 2025, Change in Accured Expenses rose 100.19% year-over-year to $25000.0; the TTM value through Sep 2025 reached -$13.1 million, down 296.61%, while the annual FY2024 figure was -$10.7 million, 230.8% down from the prior year.
  • Change in Accured Expenses reached $25000.0 in Q4 2025 per GOSS's latest filing, up from -$5.2 million in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $11.0 million in Q2 2025 to a low of -$13.1 million in Q4 2024.
  • Average Change in Accured Expenses over 4 years is -$976062.5, with a median of -$124000.0 recorded in 2023.
  • The largest YoY upside for Change in Accured Expenses was 521.25% in 2024 against a maximum downside of 1676.52% in 2024.
  • A 4-year view of Change in Accured Expenses shows it stood at -$4.1 million in 2022, then tumbled by 36.89% to -$5.7 million in 2023, then tumbled by 130.74% to -$13.1 million in 2024, then soared by 100.19% to $25000.0 in 2025.
  • Per Business Quant, the three most recent readings for GOSS's Change in Accured Expenses are $25000.0 (Q4 2025), -$5.2 million (Q3 2025), and $11.0 million (Q2 2025).